Year: 2025

GT Medical Technologies Raises $37 Million in Series D to Advance the Expansion of GammaTile® in the U.S. for Patients with Operable Brain Tumors

– Financing Led by Evidity Health Capital –  TEMPE, Ariz., Jan. 16, 2025 /PRNewswire/ -- GT Medical Technologies, Inc. (GT...

Caris Life Sciences Announces a Strategic Collaboration with Ontada® to Advance Oncology Research and the Adoption of Precision Medicine

The collaboration brings together Caris' extensive genomic data and molecular expertise with Ontada's robust clinical data and research capabilities to...

error: Content is protected !!